Basel, Switzerland

David Lehmann



 

Average Co-Inventor Count = 6.9

ph-index = 8

Forward Citations = 121(Granted Patents)


Location History:

  • Galmiz, CH (2011 - 2013)
  • Basel, CH (2009 - 2014)
  • Allschwil, CH (2014)

Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):Explore Patents

Title: The Innovative Mind of David Lehmann: A Pioneer in Pharmaceutical Inventions

Introduction: David Lehmann, based in Basel, Switzerland, is a prominent inventor with a remarkable portfolio of 15 patents. His contributions to the field of pharmaceuticals have significantly impacted the development of therapies for various medical conditions. With a keen focus on creating novel pharmaceutical compounds, Lehmann's inventions address critical health challenges.

Latest Patents: Among his latest innovations, Lehmann has developed pyridine derivatives, which relate to novel compounds with significant immunosuppressive properties. These compounds show great promise in the field of medicine for their therapeutic uses. Another notable patent involves thiazole derivatives, designed as P2Y12 receptor antagonists, which play a vital role in treating and preventing various cardiovascular diseases associated with platelet aggregation. This invention highlights Lehmann’s commitment to addressing serious health issues through innovative solutions.

Career Highlights: Throughout his career, David Lehmann has established himself as a leading figure in pharmaceutical research and development. He has worked with notable companies, including Actelion Pharmaceuticals Ltd, where he contributed to the advancement of pharmaceutical technology and product innovation. His work is characterized by a dedication to enhancing drug efficacy and safety.

Collaborations: Lehmann has collaborated with talented colleagues in the industry, including Martin Bolli and Boris Mathys. These partnerships reflect the importance of teamwork in driving innovation and creating impactful medical solutions.

Conclusion: David Lehmann's inventive spirit and dedication to pharmaceutical research have made him a significant player in the field. With his latest patents promising to improve patient outcomes and broaden therapeutic options, Lehmann continues to exemplify the role of inventors in advancing healthcare. His work not only demonstrates personal achievement but also contributes to the broader community of medical innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…